1
Med
出版年份：暂无数据 年文章数：87 投稿命中率： 开通期刊会员，数据随心看
出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看
请问投稿后编辑多久做出第一个决定？每个作者都需要确认吗？投稿已经半个月了，一直都是With Editor。
21 0
#期刊推荐#
149 0
审稿速度:2.0 | 投稿命中率:50.0偏重的研究方向：干细胞;再生医学;医学综合经验分享：经验分享：Cell的子刊，定位于Cell, Chem, Joule这个级别，未来可期！！接收领域很广，定位于转化医学，不象Cell太过生命科学（基础），也不象Lancet这一类过于临床，Med应该是二者之间，转化医学层面，虽然类似期刊竞争很激烈，但是大树下好乘凉，不要错过这个未来潜力股下面都是收稿范围：✚ Aging and health-span interventions – sarcopenia; senescence and senolytic treatments; dietary interventions; hormonal disorders✚ Biomedical engineering – new device optimization and diagnostic tools✚ Cancer – immuno-oncology; tumor evolution and cancer genetics; surgery and therapeutic modalities✚ Cardiovascular and metabolic disease – heart disease; diabetes; obesity; NAFLD/NASH✚ Genetics and cell-based therapies – medical genomics; CRISPR-based; RNAi; stem cells; organoids; transplantation✚ Health economics and public policy – global challenges; health access; public health interventions; clinical practices✚ Human microbiome – mechanistic studies of the human microbiome’s impact on disease✚ Immunology – allergy and inflammation; autoimmunity; innate immunity; graft-versus host disease; vaccinology✚ Infectious diseases – HIV/AIDS; SARS; ebola; other bacterial, viral, fungal, or parasitic infections; infectious diseases epidemiology; antimicrobials and resistance✚ Neurology – Alzheimer’s disease; dementia; cognitive dysfunctions; brain-vascular dysfunction; Parkinson’s and movement disorders; amyotrophic lateral sclerosis; depression; neuroengineering therapies
118 0
偏重的研究方向
* 我的经验分享
请问投稿后编辑多久做出第一个决定？每个作者都需要确认吗？投稿已经半个月了，一直都是With Editor。
21
#期刊推荐#
149
审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：干细胞;再生医学;医学综合
经验分享：经验分享：Cell的子刊，定位于Cell, Chem, Joule这个级别，未来可期！！
接收领域很广，定位于转化医学，不象Cell太过生命科学（基础），也不象Lancet这一类过于临床，Med应该是二者之间，转化医学层面，虽然类似期刊竞争很激烈，但是大树下好乘凉，不要错过这个未来潜力股
下面都是收稿范围：
✚ Aging and health-span interventions – sarcopenia; senescence and senolytic treatments; dietary interventions; hormonal disorders
✚ Biomedical engineering – new device optimization and diagnostic tools
✚ Cancer – immuno-oncology; tumor evolution and cancer genetics; surgery and therapeutic modalities
✚ Cardiovascular and metabolic disease – heart disease; diabetes; obesity; NAFLD/NASH
✚ Genetics and cell-based therapies – medical genomics; CRISPR-based; RNAi; stem cells; organoids; transplantation
✚ Health economics and public policy – global challenges; health access; public health interventions; clinical practices
✚ Human microbiome – mechanistic studies of the human microbiome’s impact on disease
✚ Immunology – allergy and inflammation; autoimmunity; innate immunity; graft-versus host disease; vaccinology
✚ Infectious diseases – HIV/AIDS; SARS; ebola; other bacterial, viral, fungal, or parasitic infections; infectious diseases epidemiology; antimicrobials and resistance
✚ Neurology – Alzheimer’s disease; dementia; cognitive dysfunctions; brain-vascular dysfunction; Parkinson’s and movement disorders; amyotrophic lateral sclerosis; depression; neuroengineering therapies
118